Breast Cancer 'Immunotherapy' Helps Some With Tough-to-Treat Disease

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

A minority of women with 'triple-negative' tumors responded to Tecentriq, but they responded well



You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.